Group Retreat Psilocybin Therapy Trial
Phase 2
18
about 1.8 years
18–85
1 site in WA
What this study is about
This trial is testing the safety, side effects, and effectiveness of group retreat psilocybin therapy for anxiety and depression in people with advanced cancers. The treatment involves psilocybin combined with structured discussions to help patients gain new insights about their condition. This study refines a previous study that showed psilocybin therapy was safe.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Psychotherapy
- 2.Survey Administration
- 3.Take Psilocybin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
oral
Primary: Incidence of adverse events
Secondary: Symptoms of Anxiety and Depression assessed via the Hospital Anxiety and Depression Scale (HADS): Change in Mean Total score
Psychiatry / Mental Health